AMEDISYS INC (AMED)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
---|---|---|---|---|
Revenues | - | 594,781 | 587,671 | 591,187 |
Other | - | 57,965 | 56,777 | 58,602 |
Salaries and benefits | - | 131,968 | 134,833 | 129,323 |
Depreciation and amortization | - | 4,447 | 4,774 | 4,386 |
Cost of service, inclusive of depreciation | - | 334,050 | 337,563 | 326,933 |
Non-cash compensation | - | 6,223 | 6,726 | 7,828 |
Merger-related expenses | - | 16,769 | 16,669 | 11,901 |
Total operating expenses | - | 551,422 | 557,342 | 538,973 |
Other Operating Income (Expense), Net | - | - | - | - |
Operating income | 45,578 | 43,359 | 30,329 | 52,214 |
Interest expense | - | - | - | 7,895 |
Merger termination fee | - | - | - | - |
Miscellaneous, net | 4,506 | 1,508 | 2,522 | 1,779 |
Interest income | 3,016 | 2,873 | 2,017 | 1,617 |
Interest expense | 6,415 | 6,422 | 7,772 | - |
Equity in earnings from equity method investments | 1,641 | 1,794 | 1,891 | 1,515 |
Gain on equity method investment | - | 48,093 | - | - |
Total other income (expense), net | 2,748 | 47,846 | -1,342 | -2,984 |
Income before income taxes | 48,326 | 91,205 | 28,987 | 49,230 |
Income tax expense | 19,274 | 29,384 | 12,473 | 16,657 |
Net income | 29,052 | 61,821 | 16,514 | 32,573 |
Net income attributable to noncontrolling interests | 968 | 809 | -397 | 272 |
Net income attributable to amedisys, inc | 28,084 | 61,012 | 16,911 | 32,301 |
Net income attributable to amedisys, inc. common stockholders | 0.84 | 1.84 | 0.51 | 0.98 |
Net income attributable to amedisys, inc. common stockholders | 0.85 | 1.86 | 0.52 | 0.99 |
Weighted average shares outstanding, basic (shares) | 32,849,000 | 32,793,000 | 32,745,000 | 32,706,000 |
Weighted average shares outstanding, diluted (shares) | 33,289,000 | 33,218,000 | 33,135,000 | 33,047,000 |